Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

BNGO holding history

Bionano Genomics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BNGO overviewAll 13F holders of BNGOFull Q2 2026 holdings

Shares (Q2 2026)
812
Value
$918
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BNGO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026812$918<0.1%+796+4,975.0%AddedHolders
Q1 202616$19<0.1%−9,043−99.8%ReducedHolders
Q4 20259,059$13.9K<0.1%−54,817−85.8%ReducedHolders
Q3 202563,876$109.2K<0.1%+61,206+2,292.4%AddedHolders
Q2 20252,670$8.76K<0.1%+297+12.5%AddedHolders
Q1 20252,373$6.62K<0.1%−142,532−98.4%ReducedHolders
Q4 2024144,905$41.7K<0.1%+144,829+190,564.5%AddedHolders
Q3 202476$35<0.1%−4−5.0%ReducedHolders
Q2 202480$54<0.1%−8,480−99.1%ReducedHolders
Q1 20248,560$9.50K<0.1%+8,256+2,715.8%AddedHolders
Q4 2023304$574<0.1%−10,960−97.3%ReducedHolders
Q3 202311,264$34.1K<0.1%−1,089−8.8%ReducedConverted for a 1-for-10 splitHolders
Q2 2023123,532$75.4K<0.1%−48,380−28.1%ReducedHolders
Q1 2023171,912$190.8K<0.1%+137,488+399.4%AddedHolders
Q4 202234,424$50.3K<0.1%+32,184+1,436.8%AddedHolders
Q3 20222,240$4.00K<0.1%−49,599−95.7%ReducedHolders
Q2 202251,839$72.0K<0.1%−7,964−13.3%ReducedHolders
Q1 202259,803$155.0K<0.1%−75,239−55.7%ReducedHolders
Q4 2021135,042$404.0K<0.1%+128,002+1,818.2%AddedHolders
Q3 20217,040$39.0K<0.1%+1,100+18.5%AddedHolders
Q2 20215,940$44.0K<0.1%−25,187−80.9%ReducedHolders
Q1 202131,127$252.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.